Alzamend Neuro completes Phase II clinical trial of AL001 lithium therapy Nov 19, 2025 08:01AM
Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital Nov 19, 2025 08:00AM
Alzamend Neuro to Present at the 2025 Military Health System Research Symposium Jul 28, 2025 08:00AM
Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs Jul 23, 2025 08:00AM
Alzamend Neuro (ALZN) Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital May 29, 2025 08:04AM


May 29, 2025 08:00AM Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
May 19, 2025 08:03AM Alzamend Neuro (ALZN) Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study
May 19, 2025 08:00AM Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
May 13, 2025 08:00AM Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
Mar 25, 2025 08:00AM Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital
Mar 18, 2025 08:00AM Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital
Mar 11, 2025 08:00AM Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital
Mar 4, 2025 08:11AM Alzamend Neuro (ALZN) Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital
Mar 4, 2025 08:10AM Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital
Feb 25, 2025 08:00AM Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital
Feb 19, 2025 08:04AM Alzamend Neuro (ALZN) Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital
Feb 19, 2025 08:00AM Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital